Evidence map›Paper›PMID 26234610›Full record

ArticleScientific reports2015

Establishment of a new OSCC cell line derived from OLK and identification of malignant transformation-related proteins by differential proteomics approach.

Yan Dong, Qun Zhao, Xiaoyan Ma, Guowu Ma, Caiyun Liu, Zhuwen Chen, Liyuan Yu, Xuefeng Liu, Yanguang Zhang, Shujuan Shao and 11 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Efficacious Anti-Cancer Drugs Targeting NicotinamidePharmaceuticals (Basel, Switzerland) · 2026
    Article
  3. Roles of Wnt ligands and receptors in oral squamous cell carcinoma.Journal of Zhejiang University. Science. B · 2025
    Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Biomarkers in Tumorigenesis Using Cancer Cell Lines: A Systematic ReviewAsian Pacific journal of cancer prevention : APJCP · 2017
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 5 institutions in 1 country.

Yan Dong1] College of Stomatology, Dalian Medical University, Dalian 116044, China [2] State Key Laboratory of Molecular Oncology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Qun ZhaoDalian Institute of Chemical Physics, Chinese Academy of Science, Dalian 116023, China.
Xiaoyan Ma1] College of Stomatology, Dalian Medical University, Dalian 116044, China [2] State Key Laboratory of Molecular Oncology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Guowu MaCollege of Stomatology, Dalian Medical University, Dalian 116044, China.
Caiyun Liu1] College of Stomatology, Dalian Medical University, Dalian 116044, China [2] State Key Laboratory of Molecular Oncology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Zhuwen ChenCollege of Stomatology, Dalian Medical University, Dalian 116044, China.
Liyuan Yu1] College of Stomatology, Dalian Medical University, Dalian 116044, China [2] State Key Laboratory of Molecular Oncology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Xuefeng LiuInstitute of Cancer Stem Cell, Second Affiliated Hospital, Cancer Center, Dalian Medical University, Dalian 116044, China.
Yanguang Zhang1] College of Stomatology, Dalian Medical University, Dalian 116044, China [2] State Key Laboratory of Molecular Oncology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Shujuan ShaoInstitute of Cancer Stem Cell, Second Affiliated Hospital, Cancer Center, Dalian Medical University, Dalian 116044, China.
Jing XiaoCollege of Stomatology, Dalian Medical University, Dalian 116044, China.
Jia LiState Key Laboratory of Molecular Oncology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Weimin ZhangState Key Laboratory of Molecular Oncology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Ming FuState Key Laboratory of Molecular Oncology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Lijia DongState Key Laboratory of Molecular Oncology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Xiandong YangCollege of Stomatology, Dalian Medical University, Dalian 116044, China.
Xu GuoDepartment of Engineering Mechanics, Dalian University of Technology, Dalian 116023, China.
Liyan XueDepartment of Pathology, Cancer Hospital and Cancer Institute, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Fei FangDalian Institute of Chemical Physics, Chinese Academy of Science, Dalian 116023, China.
Qimin ZhanState Key Laboratory of Molecular Oncology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Lihua ZhangDalian Institute of Chemical Physics, Chinese Academy of Science, Dalian 116023, China.
Dalian Medical University · CNChinese Academy of Medical Sciences & Peking Union Medical College · CNDalian Institute of Chemical Physics · CNDalian University of Technology · CNSecond Affiliated Hospital of Dalian Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Oral squamous cell carcinoma (OSCC) is usually preceded by the oral premalignant lesions, mainly oral leukoplakia (OLK) after repeated insults of carcinogens, tobacco. B(a)P and DMBA are key carcinogens in tobacco smoke. In the present study, for the first time we established the cancerous cell line OSCC-BD induced by B(a)P/DMBA mixture and transformed from dysplastic oral leukoplakia cell line DOK. Cell morphology, proliferation ability, migration ability, colony formation, and tumorigenicity were studied and confirmed the malignant characteristics of OSCC-BD cells. We further identified the differential proteins between DOK and OSCC-BD cells by stable isotope dimethyl labeling based quantitative proteomic method, which showed 18 proteins up-regulated and 16 proteins down-regulated with RSD < 8%. Differential proteins are mainly related to cell cycle, cell proliferation, DNA replication, RNA splicing and apoptosis. Abberant binding function, catalysis activity and transportor activity of differential proteins might contribute to the malignant transformation of OLK. Of the 34 identified differential proteins with RSD < 8%, 13 novel cancer-related proteins were reported in the present study. This study might provide a new insight into the mechanism of OLK malignant transformation and the potent biomarkers for early diagnosis, meanwhile further facilitate the application of the quantification proteomics to carcinogenesis research.

Indexed as

Cell Line, TumorCell Transformation, Neoplastic9,10-Dimethyl-1,2-benzanthraceneApoptosisBenzo(a)pyreneBiomarkers, TumorCarcinogensCarcinoma, Squamous CellCell ProliferationGene Expression RegulationHumansLeukoplakia, OralMouth NeoplasmsNeoplasm ProteinsProteomics9,10-Dimethyl-1,2-benzanthraceneBenzo(a)pyreneBiomarkers, TumorCarcinogensNeoplasm Proteins

Identifiers

PMID26234610
PMCPMC4522661
OpenAlexW1082749974

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.